









Markets
/
Stocks
/
nasdaq-epsm
/

EPSM

28.980USD

-3.620-11.10%

Close 10/17, 16:00（ET）Quotes delayed by 15 min

384.00MMarket Cap

--P/E TTM



EPSM

28.980

-3.620-11.10%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of EPSM

Currency: USD Updated: 2025-10-17

Key Insights

Its valuation is considered fairly valued,and institutional recognition is very high. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

EPSM's Score

Industry at a Glance

Industry Ranking

29 / 30

Overall Ranking

600 / 4691

Industry

Food & Drug Retailing

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 0 analysts

Current Rating

Target Price

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

EPSM Highlights

StrengthsRisks

Growing

The company is in a growing phase, with the latest annual income totaling USD 12.52M.

Overvalued

The company’s latest PE is 1397.30, at a high 3-year percentile range.

Institutional Buying

The latest institutional holdings are 167.20K shares, increasing 38.82% quarter-over-quarter.

Held by Invesco

Star Investor Invesco holds 10.38K shares of this stock.

Financial Health

Currency: USD Updated: 2025-10-17

There is no financial score for this company; the Food & Drug Retailing industry's average is 6.73.

Score

Industry at a Glance

Previous score

0.00

Change



Financials



Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings



Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency



Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential



Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns



Key Metrics

Free cash flow

No Data

EPSM's Company Valuation

Currency: USD Updated: 2025-10-17

The company’s current valuation score is 1.00, which is lower than the Food & Drug Retailing industry's average of 6.74. Its current P/E ratio is 1397.30, which is 376.19% below the recent high of 6653.81 and 84.03% above the recent low of 223.19.

Score

Industry at a Glance

Previous score

1.00

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 29/30

No Data

Earnings Forecast

Currency: USD Updated: 2025-10-17

There is no earnings forecast score for this company; the Food & Drug Retailing industry's average is 7.62.

Score

Industry at a Glance

Previous score

0.00

Change

Support & Resistance

No Data

No Data

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-10-17

The company’s current price momentum score is 8.97, which is higher than the Food & Drug Retailing industry's average of 7.19. Sideways: Currently, the stock price is trading between the resistance level at 44.62 and the support level at 11.18, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

9.18

Change

-0.21

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(3)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

0.575

Neutral

RSI(14)

48.286

Neutral

STOCH(KDJ)(9,3,3)

42.936

Sell

ATR(14)

8.181

Low Volatility

CCI(14)

4.192

Neutral

Williams %R

40.281

Buy

TRIX(12,20)

-0.275

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(4)

Neutral(0)

Buy(2)

Indicators

Value

Direction

MA5

32.574

Sell

MA10

32.720

Sell

MA20

29.685

Sell

MA50

30.413

Sell

MA100

24.320

Buy

MA200

19.746

Buy

Institutional Confidence

Currency: USD Updated: 2025-10-17

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Citadel Advisors LLC

99.14K

HRT Financial LP

28.32K

Quadrature Capital LLP

18.67K

UBS Financial Services, Inc.

8.46K

-71.70%

Geode Capital Management, L.L.C.

8.00K

RBC Capital Markets Wealth Management

3.94K

BNP Paribas Securities Corp. North America

400.00

Tower Research Capital LLC

270.00

Tam (Son I)

10.80M

Risk Assessment

Currency: USD Updated: 2025-10-17

There is no risk assessment score for the company; the Food & Drug Retailing industry's average is 5.72. The company's beta value is 0.00. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.